| The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis A Jain, K Cheng Journal of controlled release 245, 27-40, 2017 | 264 | 2017 |
| Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy A Barve, A Jain, H Liu, Z Zhao, K Cheng Acta biomaterialia 113, 501-511, 2020 | 109 | 2020 |
| Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy H Liu, Z Zhao, L Zhang, Y Li, A Jain, A Barve, W Jin, Y Liu, J Fetse, ... Journal for immunotherapy of cancer 7, 1-14, 2019 | 90 | 2019 |
| Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis Z Chen, A Jain, H Liu, Z Zhao, K Cheng Journal of Pharmacology and Experimental Therapeutics 370 (3), 695-702, 2019 | 84 | 2019 |
| Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery A Jain, A Barve, Z Zhao, W Jin, K Cheng Molecular pharmaceutics 14 (5), 1517-1527, 2017 | 81 | 2017 |
| Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex RS Shukla, A Jain, Z Zhao, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 12 (5), 1323-1334, 2016 | 64 | 2016 |
| Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer Z Zhao, Y Li, H Liu, A Jain, PV Patel, K Cheng Science advances 6 (29), eabb0616, 2020 | 58 | 2020 |
| Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells Z Zhao, Y Li, A Jain, Z Chen, H Liu, W Jin, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 14 (1), 51-61, 2018 | 53 | 2018 |
| Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer Z Zhao, Y Li, R Shukla, H Liu, A Jain, A Barve, K Cheng Theranostics 9 (15), 4508-4524, 2019 | 47 | 2019 |
| Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX Z Chen, H Liu, A Jain, L Zhang, C Liu, K Cheng Theranostics 7 (12), 2982-2995, 2017 | 39 | 2017 |
| Development of a tumor-responsive nanopolyplex targeting pancreatic cancer cells and stroma Y Li, Z Zhao, H Liu, JP Fetse, A Jain, CY Lin, K Cheng ACS applied materials & interfaces 11 (49), 45390-45403, 2019 | 35 | 2019 |
| An enzyme-responsive conjugate improves the delivery of a PI3K inhibitor to prostate cancer A Barve, A Jain, H Liu, W Jin, K Cheng Nanomedicine: Nanotechnology, Biology and Medicine 12 (8), 2373-2381, 2016 | 34 | 2016 |
| Targeted Delivery of an siRNA/PNA Hybrid Nanocomplex Reverses Carbon Tetrachloride‐Induced Liver Fibrosis A Jain, A Barve, Z Zhao, JP Fetse, H Liu, Y Li, K Cheng Advanced Therapeutics 2 (8), 1900046, 2019 | 22 | 2019 |
| Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists A Zacharia, E Harberts, SM Valencia, B Myers, C Sanders, A Jain, ... Vaccine 39 (2), 292-302, 2021 | 20 | 2021 |
| Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery P Patel, J Fetse, CY Lin, Y Guo, MR Hasan, M Nakhjiri, Z Zhao, A Jain, ... Acta biomaterialia 154, 374-384, 2022 | 13 | 2022 |
| Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy H Liu, Y Liu, Z Zhao, Y Li, B Mustafa, Z Chen, A Barve, A Jain, X Yao, G Li, ... Frontiers in Immunology, 1345, 2022 | 8 | 2022 |
| Noncovalent Attachment of Chemical Moieties to siRNAs Using Peptide Nucleic Acid as a Complementary Linker W Jin, A Jain, H Liu, Z Zhao, K Cheng ACS applied bio materials 1 (3), 643-651, 2018 | 4 | 2018 |
| Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp. T Lu, S Das, DR Howlader, A Jain, G Hu, ZK Dietz, Q Zheng, ... Frontiers in Immunology 14, 1194912, 2023 | 2 | 2023 |
| Preformulation characterization and the effect of ionic excipients on the stability of a novel DB fusion protein A Jain, G Hu, SSK Ratnakaram, DK Johnson, WD Picking, WL Picking, ... Journal of pharmaceutical sciences 110 (1), 108-123, 2021 | 2 | 2021 |
| Subunit-based vaccines: challenges in developing protein-based vaccines SF Ausar, NR Larson, Y Wei, A Jain, CR Middaugh Practical Aspects of Vaccine Development, 79-135, 2022 | 1 | 2022 |
Zhen ZhaoHebei University of Technology, Tianjin, China在 hebut.edu.cn 的电子邮件经过验证
